Advocacy intelligence hub — real-time data for patient organizations
Guangdong Hengrui Pharmaceutical Co., Ltd — PHASE2
Shandong First Medical University — PHASE2
Boehringer Ingelheim — PHASE3
Oregon Health and Science University — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
EMILIE GARRIDO PRADALIE
APHM DRIC
Saakshi Khattri, MD
Icahn School of Medicine at Mount Sinai
📍 NEW YORK, NY
Arena CT.gov Administrator
Arena Pharmaceuticals
David F Fiorentino, MD
Stanford University
📍 STANFORD, CA
Brian J. Simmons
Dartmouth-Hitchcock Medical Center
William W Huang
Wake Forest University Health Sciences